Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Platelet Activity Assay vs LTA in Healthy and Obese Volunteers
NCT04822363Phase 1Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2021
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of aspirin and clopidogrel in thromboembolism, sponsored by Beth Israel Deaconess Medical Center. Started Aug 2021; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT04822363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04822363.